The implanted pump in metastatic colorectal cancer of the liver: Risk versus benefit
- 31 May 1985
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 149 (5) , 595-598
- https://doi.org/10.1016/s0002-9610(85)80133-1
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A Prospective Phase II Clinical Trial of Continuous FUDR Regional Chemotherapy for Colorectal Metastases to the LiverAnnals of Surgery, 1983
- Metastatic disease in the liver from colorectal cancer: An appraisal of liver surgeryWorld Journal of Surgery, 1982
- The practicality of chronic hepatic artery infusion therapy of primary and metastatic hepatic malignancies: Ten-year results of 124 patients in a prospective protocolCancer, 1981
- Lack of effectiveness of combined 5-fluorouracil and methyl-ccnu therapy in advanced colorectal cancerCancer, 1977
- Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU.A southwest oncology group studyCancer, 1976
- The natural history of primary and secondary malignant tumors of the liver I.The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomyCancer, 1969
- Hepatic resection for metastatic cancerThe American Journal of Surgery, 1967
- The natural history of carcinoma of the colon and rectumThe American Journal of Surgery, 1964
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958